Pentadecapeptide BPC 157, Cimetidine, Ranitidine, Bromocriptine, and Atropine Effect in Cysteamine Lesions in Totally Gastrectromized Rats (A Model for Cytoprotective Studies)

@article{Sikiri1997PentadecapeptideB1,
  title={Pentadecapeptide BPC 157, Cimetidine, Ranitidine, Bromocriptine, and Atropine Effect in Cysteamine Lesions in Totally Gastrectromized Rats (A Model for Cytoprotective Studies)},
  author={P Sikiri{\'c} and Darko Mikus and Sven Seiwerth and Željko Grabarevi{\'c} and Josip Peric and Pasko Konjevoda and Darko Perovi{\'c} and Ljubica Jurina and Stipislav Jadrijevi{\'c} and Nikola Jelovac and Pavao Mikli{\'c} and Gojko Buljat and Rudolf Ru{\vc}man and Marijan Petek and Vjekoslav Jagi{\'c} and Branko Turkovi{\'c} and Ivo Rotkvi{\'c} and Stjepan Mi{\vs}e and Ivan Zori{\vc}i{\'c} and Miro Han{\vz}eva{\vc}ki and Jadranka {\vS}eparovi{\'c} and Miroslav Gjura{\vs}in and Anton Marovi{\'c}},
  journal={Digestive Diseases and Sciences},
  year={1997},
  volume={42},
  pages={1029-1037}
}
A superior effectiveness in various lesionassays was noted for the novel pentadecapeptide BPC 157,originated from human gastric juice protein (BPC) andclaimed to be a cytoprotective agent. From this viewpoint, as a previously untreatedexperimental improvement to create an acid-freeenvironmental for cytoprotection studies, totalgastrectomy was done 24 hr… CONTINUE READING